Comparison table: drugs for Parkinson's disease.
出版信息
Med Lett Drugs Ther. 2017 Nov 20;59(1534):e194-e196.
PMID:29136402
Abstract
摘要
相似文献
1
Comparison table: drugs for Parkinson's disease.
Med Lett Drugs Ther. 2017 Nov 20;59(1534):e194-e196.
2
Drugs for Parkinson's disease.
Med Lett Drugs Ther. 2017 Nov 20;59(1534):187-194.
3
Safinamide (Xadago) for Parkinson's disease.沙芬酰胺（Xadago）用于治疗帕金森病。
Med Lett Drugs Ther. 2017 Sep 11;59(1529):151-153.
4
Levodopa and the progression of Parkinson's disease.左旋多巴与帕金森病的进展
N Engl J Med. 2005 Mar 31;352(13):1386; author reply 1386. doi: 10.1056/NEJM200503313521324.
5
Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications.
Neurology. 1998 Feb;50(2):573-4. doi: 10.1212/wnl.50.2.573-b.
6
Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience.度洛西汀对帕金森病运动和情绪症状的影响：一项开放标签临床经验。
J Neurol Sci. 2017 Apr 15;375:186-189. doi: 10.1016/j.jns.2017.01.066. Epub 2017 Jan 25.
7
Future delivery systems for apomorphine in patients with Parkinson's disease.帕金森病患者阿扑吗啡的未来给药系统。
Adv Neurol. 1999;80:535-44.
8
Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease.Duopa——一种用于帕金森病的卡比多巴/左旋多巴肠内悬浮液。
Med Lett Drugs Ther. 2015 Aug 3;57(1474):112.
9
Future strategies for the treatment of Parkinson's disease.帕金森病的未来治疗策略。
Adv Neurol. 1993;60:636-40.
10
Parkinson's disease: initial treatment of motor disorders.
Prescrire Int. 2015 Sep;24(163):215-7.
Zotero 插件